HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Imidazole → 2-(2-Chloro-4-(1H-imidazol-1-yl)phenyl)-5-((3aR,6aS)-5-methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-1,3,4-thiadiazole

HRID 579343
Print

Reaction equation

HRID 579343 reaction equation
N1C=CC=CC=1C1NC2C=CC=CC=2N=1.C(=O)([O-])[O-].[Cs+].[Cs+].[NH:22]1[CH:26]=[CH:25][N:24]=[CH:23]1.[Cl:27][C:28]1[CH:33]=[C:32](I)[CH:31]=[CH:30][C:29]=1[C:35]1[S:36][C:37]([N:40]2[CH2:47][C@@H:46]3[C@@H:42]([CH2:43][N:44]([CH3:48])[CH2:45]3)[CH2:41]2)=[N:38][N:39]=1>CCOC(C)=O.CO.[Cu]I.CN(C=O)C>[Cl:27][C:28]1[CH:33]=[C:32]([N:22]2[CH:26]=[CH:25][N:24]=[CH:23]2)[CH:31]=[CH:30][C:29]=1[C:35]1[S:36][C:37]([N:40]2[CH2:41][C@@H:42]3[C@@H:46]([CH2:45][N:44]([CH3:48])[CH2:43]3)[CH2:47]2)=[N:38][N:39]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

9

Reactant 4

HCID 795ImidazoleHCID 10796Cesium carbonateHCID 708212-(2'-Pyridyl)benzimidazoleHCID 867271642-(2-Chloro-4-iodophenyl)-5-((3aR,6aS)-5-methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-1,3,4-thiadiazole

Product 1

HCID 867271662-(2-Chloro-4-(1H-imidazol-1-yl)phenyl)-5-((3aR,6aS)-5-methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-1,3,4-thiadiazole
Yield 17%

Reagents, catalysts & solvents 4

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)CatalystHCID 887MethanolSolventHCID 6228DimethylformamideSolventHCID 8857Ethyl AcetateSolvent

Conditions

Temperature
60 °C

Procedure

DMF (0.75 mL) was added to a nitrogen flushed flask containing copper(I) iodide (13 mg, 0.067 mmol), 2-(2-pyridyl)benzimidazole (13 mg, 0.067 mmol) and cesium carbonate (273 mg, 0.839 mmol). The resulting suspension was heated at 60° C. for 1 hour. 1H-Imidazole (23 mg, 0.336 mmol) and 2-(2-chloro-4-iodophenyl)-5-((3aR,6aS)-5-methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-1,3,4-thiadiazole (150 mg, 0.336 mmol) were added and the mixture was heated at 90° C. for ˜18 hours. The reaction mixture was diluted with EtOAc (30 mL) and filtered through celite. The filtrate was concentrated in vacuo to afford a green oil. The crude material was taken up in MeOH (30 mL) and SiliaMetS-DMT (0.61 mmol/g, 1.098 g, 0.67 mmol) was added. The resulting suspension was stirred at room temperature for 72 hours then the SiliaMetS-DMT was removed by vacuum filtration and the filtrate was concentrated in vacuo to afford the crude product as a yellow oil. The crude material was purified by mass directed preparative HPLC under acidic conditions (TFA modified). The product containing fractions were combined, loaded onto a 1 g SCX cartridge (pre-wet with MeOH) and the cartridge washed with MeOH (10 mL) then flushed with 7M NH3 in MeOH (10 mL). The MeOH/NH3 was removed in vacuo to afford the title compound as a white solid (22 mg, 17% yield). LC-MS: Rt 0.52 min; MS m/z 387.0 [M+H]+ [Method D]. 1H NMR (400 MHz, DMSO-d6) δ ppm 8.44 (s, 1H), 8.15 (d, J=8.59 Hz, 1H), 8.06 (d, J=2.02 Hz, 1H), 7.91 (s, 1H), 7.83 (dd, J=8.59, 2.53 Hz, 1H), 7.15 (s, 1H), 3.72 (dd, J=10.36, 8.34 Hz, 2H), 3.37 (dd, J=10.36, 2.78 Hz, 2H), 3.00 (br. s., 2H), 2.56 (br. s., 4H), 2.26 (s, 3H).

Workup

  1. temperaturethe mixture was heated at 90° C. for ˜18 hours
  2. filtrationfiltered through celite
  3. concentrationThe filtrate was concentrated in vacuo
  4. customto afford a green oil
  5. additionSiliaMetS-DMT (0.61 mmol/g, 1.098 g, 0.67 mmol) was added
  6. customthe SiliaMetS-DMT was removed by vacuum filtration
  7. concentrationthe filtrate was concentrated in vacuo
  8. customto afford the crude product as a yellow oil
  9. customThe crude material was purified by mass
  10. additionThe product containing fractions
  11. washthe cartridge washed with MeOH (10 mL)
  12. customthen flushed with 7M NH3 in MeOH (10 mL)
  13. customThe MeOH/NH3 was removed in vacuo

Sources & evidence

ORD record
ord-2ac68cf11f6442c78be73a1a18eb26ee
Source dataset
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09040712B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes